Literature DB >> 18384122

Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain.

Wei Wang1, Wen Wang, Yayun Wang, Jing Huang, Shengxi Wu, Yun-Qing Li.   

Abstract

Astrocyte activation is involved in the neuropathic pain. As a glutamate scavenger, the glutamate transporter-1 (GLT-1) is exclusively expressed on the astrocytes and probably correlates with astrocyte activation. In the present study, we attempted to clarify the temporal changing courses of astrocyte activation and GLT-1 expression, as well as their correlations induced by a neuropathic pain model, namely, spinal nerve ligation (SNL) in which rapidly appearing (<3 days) and persistent (>21 days) mechanical allodynia and thermal hyperalgesia were presented. Immunofluorescent staining showed that GLT-1 was expressed exclusively in most (not all) of the astrocytes, even when the GLT-1 expression reached its peak. The expression of GLT-1 displayed an interesting biphasic change, with an initial up-regulation followed by a down-regulation after SNL. Our results also demonstrated that SNL induced a marked and long-term (>21 days) activation of astrocytes in the ipsilateral spinal dorsal horn. These results suggest that astrocyte activation, the change of GLT-1 expression and the potential relationship between them might play key roles in the induction and/or maintenance of neuropathic pain. The present results provide novel clues in understanding the mechanisms underlying the involvement of astrocytes and GLT-1 in the neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384122     DOI: 10.1002/ar.20673

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  15 in total

1.  Up-regulation of spinal glutamate transporters contributes to anti-hypersensitive effects of valproate in rats after peripheral nerve injury.

Authors:  Shotaro Hobo; James C Eisenach; Ken-ichiro Hayashida
Journal:  Neurosci Lett       Date:  2011-07-23       Impact factor: 3.046

Review 2.  Targeting astrocyte signaling for chronic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

3.  Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain.

Authors:  Wei Wang; Wen Wang; Xiaopeng Mei; Jing Huang; Yanyan Wei; Yayun Wang; Shengxi Wu; Yunqing Li
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

4.  Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain ketamine, astrocytic inhibitor and pain.

Authors:  Xiao-Peng Mei; Wei Wang; Wen Wang; Chao Zhu; Lei Chen; Ting Zhang; Li-Xian Xu; Sheng-Xi Wu; Yun-Qing Li
Journal:  Mol Pain       Date:  2010-09-06       Impact factor: 3.395

5.  Supraspinal glial-neuronal interactions contribute to descending pain facilitation.

Authors:  Feng Wei; Wei Guo; Shiping Zou; Ke Ren; Ronald Dubner
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

6.  Rapid elevation of calcium concentration in cultured dorsal spinal cord astrocytes by corticosterone.

Authors:  Junwei Zeng; Min Li; Zhi Xiao; Yuanshou Chen; Quanzhong Chang; Hong Tian; Huan Jin; Xiaohong Liu
Journal:  Neurochem Res       Date:  2012-11-24       Impact factor: 3.996

7.  Chronic at-level thermal hyperalgesia following rat cervical contusion spinal cord injury is accompanied by neuronal and astrocyte activation and loss of the astrocyte glutamate transporter, GLT1, in superficial dorsal horn.

Authors:  Rajarshi Putatunda; Tamara J Hala; Jeannie Chin; Angelo C Lepore
Journal:  Brain Res       Date:  2014-05-14       Impact factor: 3.252

8.  Spinal toll like receptor 3 is involved in chronic pancreatitis-induced mechanical allodynia of rat.

Authors:  Nian-Song Qian; Yong-Hui Liao; Quan-Xing Feng; Yu Tang; Ke-Feng Dou; Kai-Shan Tao
Journal:  Mol Pain       Date:  2011-02-22       Impact factor: 3.395

9.  The role of purinergic receptors in cancer-induced bone pain.

Authors:  Sarah Falk; Maria Uldall; Anne-Marie Heegaard
Journal:  J Osteoporos       Date:  2012-10-03

10.  Inhibiting spinal neuron-astrocytic activation correlates with synergistic analgesia of dexmedetomidine and ropivacaine.

Authors:  Huang-Hui Wu; Jun-Bin Yin; Ting Zhang; Yuan-Yuan Cui; Yu-Lin Dong; Guo-Zhong Chen; Wen Wang
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.